Results

Total Results: 7,520 records

Showing results for "analyzing".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/machine-learning-tools-appendix-c.xlsx
    January 01, 2024 - Search screening tools PMID Authors Title Pubyear Tool_name Environment Access Model Model_type ESP_Task Specific_ESP_task Training Inputs Outputs Notes Purported_use Reference_standard Manual_sensitivity Manual_precision Positivity_threshold Stopping_rule Nruns datasets Summary_measure Burden Burden_dispersion Sensit…
  2. www.ahrq.gov/sites/default/files/2024-05/wendel-hummell-report.pdf
    January 01, 2024 - Final Progress Report: Care and Safety Practices During the COVID-19 Pandemic in Home-Based Long-Term Services and Supports Title: Care and Safety Practices during the COVID-19 Pandemic in Home-Based Long-Term Services and Supports Principle Investigator and Team Members: Carrie Wendel-Hummell, PhD; PI1 Tracey LaP…
  3. www.ahrq.gov/sites/default/files/2024-01/bates-report.pdf
    January 01, 2024 - Final Progress Report: Improving Medication Safety Across Clinical Settings FINAL REPORT: November 29, 2007 Improving Medication Safety Across Clinical Settings Principal Investigator: David W. Bates; dbates@…
  4. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-203-fullreport.pdf
    April 10, 2017 - Initial Risk Assessment for Immobility-Related Pressuer Ulcer Within 24 Hours of Pediatric Intensive Care Unit (PICU) Admission Initial Risk Assessment for Immobility-Related Pressure Ulcer Within 24 Hours of Pediatric Intensive Care Unit (PICU) Admission Section 1. Basic Measure Information 1.A. Measure Name In…
  5. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-200-fullreport.pdf
    November 01, 2017 - Appropriateness of Red Cell Transfusions in the Pediatric Intensive Care Unit Appropriateness of Red Cell Transfusions in the Pediatric Intensive Care Unit Section 1. Basic Measure Information 1.A. Measure Name Appropriateness of Red Cell Transfusions 1.B. Measure Number 0200 1.C. Measure Description Plea…
  6. www.ahrq.gov/sites/default/files/2024-02/gurses-report.pdf
    January 01, 2024 - Final Progress Report: Patient-Centric Risk Model for Medication Safety During Care Transitions Final Progress Report of “Patient-Centric Risk Model for Medication Safety During Care Transitions” 1. TITLE PAGE Project Title: Patient-Centric Risk Model for Medication Safety During Care Transitions Principal Investi…
  7. www.uspreventiveservicestaskforce.org/uspstf/document/c-reactive-protein-as-a-risk-factor-for-coronary-heart-disease-a-systematic-review-and-meta-analyses-for-the-us-preventive-services-task-force/coronary-heart-disease-screening-using-non-traditional-risk-factors-2009
    July 15, 2008 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force Coronary Heart Disease:…
  8. www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/ade.pdf
    November 11, 2019 - Making Healthcare Safer Practices: 9. Reducing Adverse Drug Events in Older Adults Reducing Adverse Drug Events in Older Adults 9-1 9. Reducing Adverse Drug Events in Older Adults Authors: Tara R. Earl, Ph.D., M.S.W., Nicole D. Katapodis, M.P.H., and Stephanie R. Schneiderman, M.P.P. Reviewers: Scott Winiecki, M.…
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/multiple-sclerosis_executive.pdf
    April 01, 2015 - 1 Comparative Effectiveness Review Number 150 Decisional Dilemmas in Discontinuing Prolonged Disease-Modifying Treatment for Multiple Sclerosis Executive Summary Background Multiple sclerosis (MS) is a variably debilitating disease characterized by demyelination (deterioration of the protective myelin sheat…
  10. www.ahrq.gov/sites/default/files/wysiwyg/diagnostic/resources/issue-briefs/dxsafety-ehr-impact.pdf
    August 01, 2024 - ML can significantly improve diagnostic safety through: ■ Enhanced pattern recognition (e.g., analyzing
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/antenatal-care.pdf
    January 01, 2020 - KIs are not involved in analyzing the evidence or writing the report and have not reviewed the report
  12. www.ahrq.gov/sites/default/files/wysiwyg/sops/surveys/hospital/hospitalresourcelist.pdf
    January 01, 2019 - Staff can use this decision tree when analyzing an error or adverse event in an organization to help
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/hypertension-pulmonary-arterial_research-protocol.pdf
    January 30, 2013 - Key Informants are not involved in analyzing the evidence or writing the report and have not reviewed
  14. digital.ahrq.gov/sites/default/files/docs/publication/r36hs023349-islam-final-report-2015.pdf
    January 01, 2015 - Previous studies were effective not only in analyzing cognitive challenges but also in eliciting the
  15. digital.ahrq.gov/sites/default/files/docs/publication/r21hs020323-mollica-final-report-2014.pdf
    January 01, 2014 - The HPRT-KI team is still in the process of analyzing these possible factors (such as limited time studying
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/ear-infection_research-protocol.pdf
    August 07, 2012 - Key Informants are not involved in analyzing the evidence or writing the report and have not reviewed
  17. www.ahrq.gov/sites/default/files/2025-02/meenan-report.pdf
    January 01, 2025 - GLMM were chosen because of their advantages in analyzing data  that exhibit within‐cluster correlation
  18. www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/mrsa/123-mrsa-toolkit-implementation-guide.docx
    October 01, 2024 - Evaluate: Evaluation is the process of collecting, analyzing, and reporting data.
  19. www.ahrq.gov/sites/default/files/2024-09/linzer-schwartz-report.pdf
    January 01, 2024 - First, we are still analyzing the impact of physician-related outcomes on care quality and patient
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-biopsy-update_research-protocol.pdf
    September 20, 2013 - Key Informants are not involved in analyzing the evidence or writing the report and have not reviewed